Nautilus Bio (NAUT) Revenue & Revenue Breakdown
Nautilus Bio Revenue Highlights
00
Nautilus Bio Revenue by Period
Nautilus Bio Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | - |
Nautilus Bio Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $8.21M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | - |
Nautilus Bio Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
BEAM | Beam Therapeutics | $377.71M | $14.27M |
KYMR | Kymera Therapeutics | $78.59M | $3.74M |
DTIL | Precision BioSciences | $48.73M | $576.00K |
CRBU | Caribou Biosciences | $34.48M | $3.46M |
FHTX | Foghorn Therapeutics | $34.16M | $7.81M |
RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
MOLN | Molecular Partners | $7.04M | $2.74M |
HCWB | HCW Biologics | $2.84M | $426.42K |
IPSC | Century Therapeutics | $2.23M | $791.00K |
FIXX | Q32 Bio | $1.16M | - |
MNOV | MediciNova | $1.00M | - |
ANEB | Anebulo Pharmaceuticals | - | - |
RZLT | Rezolute | - | - |
CCCC | C4 Therapeutics | - | - |
BCAB | BioAtla | - | $11.00M |
CYT | Cyteir Therapeutics | - | - |
ELYM | Eliem Therapeutics | - | - |
PMVP | PMV Pharmaceuticals | - | - |
NAUT | Nautilus Bio | - | - |
CSBR | Champions Oncology | - | - |